Background-Hypertension treatment and control remain low worldwide. Strategies to improve blood pressure control have been implemented in the United States and around the world for several years. This study was designed to assess improvement in blood pressure control over a 10-year period in a large cohort of patients in the Department of Veterans Affairs. 
I mprovement in hypertension treatment and control has become a top priority for many institutions and healthcare organizations. [1] [2] [3] [4] [5] [6] In the United States, after the landmark studies from the Department of Veterans Affairs (VA) published in the late 1960s and early 1970s, 7, 8 numerous institution and community-based programs were established to improve awareness, treatment, and control of hypertension. Since then, reports have indicated steady improvement in control rates across the nation. In the VA, hypertension screening and treatment clinics were established, and organized interventions have been implemented system-wide. Numerous approaches have been used to address patient, provider, and healthcare system barriers to facilitate better blood pressure (BP) control. Interventions targeted improvement in patient involvement and compliance, reversal of physician inertia, improvement in lifestyle modifications, and pharmacological therapy. In January 2000, the Department of Health and Human Services launched the Healthy People 2010 initiative, a national health promotion and disease prevention initiative that included aggressive goals for BP control. 9 -11 Despite these efforts, the number of patients whose hypertension is treated and controlled in the United States and around the world remains low.
Clinical Perspective on p 2468
In the present study, we assessed improvement in BP control in a large population followed up in the VA system. Data were obtained from the VA electronic health records known as VistA (Veterans health Information Systems and Technology Architecture). The study protocol was approved by the VA Institutional Review Board.
Methods

Setting
The VA's electronic health record system was first deployed in 1982 as the Decentralized Hospital Computer Program. The Computerized Patient Record System, with a user-friendly graphical user interface, was implemented system-wide in 1997. The system is searchable and allows individual medical centers to control the care of the entire patient population. Performance measures to monitor and control quality of care were integrated into the Computerized Patient Record System in 1998. A vital sign package that included BP, pulse rate, respirations, weight, and height was incorporated in the system, and data could be entered directly into the database at the time of each visit. Built-in reminders notified the provider when the last BP was Ͼ140/90 mm Hg. Reminders also prompted physicians to treat elevated BP with a combination of medication and lifestyle modification. Patients with elevated BP were seen at frequent intervals until BP was controlled, then follow-up visits were scheduled at 3-month intervals. Patients with resistant or difficult to control hypertension were referred to specialized hypertension clinics. The ability to assess BP control was enhanced in 2000 by a combination of the databases housed at individual VA medical centers into a systemwide database, the Health Data Repository.
Subjects
All veteran patients receiving health care in VA medical centers in 15 cities (Anchorage, AK; Baltimore, MD; Boston, MA; Chicago, IL; Washington, DC; Fargo, ND; Honolulu, HI; Houston, TX; Los Angeles, CA; Miami, FL; Minneapolis, MN; New York, NY; Philadelphia, PA; Portland, OR; and San Juan, Puerto Rico) with BP readings in the VA Vital Signs Database during the period of October 1999 to August 2010 were included. BP readings before September 2000 were only used to identify patients with hypertension, whereas readings after September 2000 were used to assess BP level and hypertension control rates. Medical centers were chosen to represent a range of geographic areas across the United States with varied climates. Individual patient data files were deidentified and downloaded for analysis on a personal computer running SAS software (version 9.2, Cary, NC).
Measures
BP measurements were taken by trained healthcare professionals (nurses, physician assistants, and attending physicians) who were instructed to follow standard procedures for BP measurement. Patients were seated in a comfortable position with the back supported and legs not crossed, and BP was taken after 3 to 5 minutes of rest. BP was taken at least twice if elevated and was entered into the vital sign package. In some centers, it was mandated that BP be rechecked by the attending physician if it was found to be elevated by the clinic nurse. Standard cuffs were used in most patients, but large cuffs were available for patients with large arm circumference. All BP readings, age, race, sex, height, and weight were recorded. Records were reviewed anonymously. An elevated BP reading was defined as a systolic BP Ͼ140 mm Hg or diastolic BP Ͼ90 mm Hg. Hypertensive patients were defined as having Ն3 days with elevated BP readings, using the lowest reading of the day. Normotensive patients were defined as those patients with Ն3 days of BP readings but no days with BP elevated. Patients with Ն3 readings but only 1 or 2 days with elevated BPs were not classified, and patients with Ͻ3 readings were excluded from the present analysis. All months with BP readings were examined for normotensive patients. Only months with readings after the patient was identified as being hypertensive (ie, after the patient's third day with elevated readings) were used for patients with hypertension. Age at entry into the data set was used, ie, on the first day with BP (for normotensive subjects) or on the date of the third elevated reading (for patients with hypertension).
Data Analysis
BP readings were dropped if any of the following was true: Missing systolic or diastolic, systolic less than diastolic, systolic Ͼ300 mm Hg, systolic Ͻ60 mm Hg, diastolic Ͻ30 mm Hg, or diastolic Ͼ180 mm Hg. For each day, a subject was considered to be normotensive if systolic BP was Յ140 mm Hg and diastolic BP was Յ90 mm Hg. Computation of yearly and seasonal changes in the percentage of hypertensive subjects whose BP returned to normal was based on monthly readings. For every subject, the last reading of each month was used to represent that calendar month. Months with no readings for a given patient were not imputed for that patient. The percentage of patients who were normotensive for each month was calculated based on all patients with readings for that month. Yearly change in the percentage of patients who were normotensive was calculated for the period from September 2000 to August 2010. The confidence interval (CI) for this change was computed with the mean of each month's change between those years (eg, December 2009 minus December 2000, January 2010 minus January 2001). Seasonal variability was quantified by calculating the mean peak-to-troughto-peak distance for the last 10 years of the study period with the CI estimated using an N of 10 years. The percentage controlled per month was then examined by sex, race (black, Hispanic, white, other), city, and age group (Ͻ55, 55-70, Ͼ70 -80, Ͼ80 years). Age was defined at the first BP reading for those with normal BP and at the first BP reading after being identified as hypertensive (ie, the first reading after the third elevated reading) for patients with hypertension. Using the monthly BP values as defined above, we also examined the mean systolic and diastolic BP per month in each group.
Univariate comparisons of year effects were made between subgroups of patients based on age, race, sex, and latitude by use of 2-tailed independent-group t tests. The 95% CIs were calculated with the formula meanϮ1.96 (SD/͌n).
Multivariable modeling techniques were used to examine whether patient age, sex, race, city, or time in treatment had independent effects on BP control rate. For this analysis, the percentage of months controlled in each calendar year was calculated for each hypertensive subject. Multiple regression (using a general linear model as implemented in the GLM procedure in SAS) was used to examine prediction models for the percentage of months when BP was controlled during the last calendar year available for each subject. Predictors included age group (Ͻ55, 55 to Ͻ70, 70 to Ͻ80, and Ն80 years), sex, race, city, and number of months in the data set after the subject was identified as hypertensive. Adjusted final percent elevated (the percentage of months with elevated BP in the final year, adjusted for the other covariates), was obtained by use of the least squares means option in the SAS GLM procedure. In large data sets, changes over time can occur because of different patients being in the cohort at different time points. To determine the significance of within-subject changes over time, repeated-measures ANOVA (with the GLM procedure in SAS) was used to examine changes over time in the percentage of months when BP was controlled. Change from the calendar year in which each subject was identified as being hypertensive to their last calendar year in the data set was examined first. Within-subject changes for subjects in the data set during calendar year 2001 compared with 2009, as well as 2001 versus 2005, were also examined. PϽ0.05 was considered significant. Data analysis was performed by one of the authors (R.L.A.) using SAS (version 9.2, Cary, NC).
Results
The overall sample included 1.54 million subjects and 53.3 million BP readings from September 2000 through August 2010. Of these, 582 881 patients were identified as hypertensive and 260 924 as normotensive. The remaining patients either had Ͻ3 readings, too few to be classified (383 439), or had Յ2 elevated readings (279 191), not enough to qualify them as clearly hypertensive, and were excluded from the present study. At the time point of the month when the patient was identified as having hypertension (the third elevated reading), the mean age was 61.9Ϯ13.4 years, and 96.0% were male. Race was not specified in 50.8% of the population. Of those declaring their race, 52.3% were white, 25.1% were black, 21.1% were Hispanic, and 1.5% were classified as other (Asian, Native American). The average number of days with BP readings was 44.7.0Ϯ69.8 per subject. Compared
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with patients with normal BP, patients with hypertension were significantly older, were more likely to be male and black, and had more BP readings (all PϽ0.0001; Table) . There were small increases across years in the proportion of females and younger patients, and there were small changes in the race mix (Table) . the same level of control as in the other 2 groups by the year 2010 (PϽ0.0001 versus whites and Hispanics; Figure 2 ). The unspecified group followed the same pattern as the black group from 2005 to 2010. The association of age with BP control rates was also examined (Figure 3) . Hypertension in younger patients was better controlled for the first 3 years, but after the year 2004, control rates became similar among all age groups, and curves appeared almost superimposed until 2006. In the last 3 years of follow-up, the middle and older age groups demonstrated better control rates.
The association of sex with control rates was also examined. Although the female hypertensive population (nϭ23 501) was much smaller than the male hypertensive population Figure 2 . Percentage of patients with hypertension who exhibited normal blood pressure each month, stratified by race/ethnicity. In the year 2000, white patients exhibited the best control rates, followed by blacks and Hispanics. Patients in the nonspecified group had the worse control rates. There was a continuous improvement in yearly control rates among all ethnic groups. However, after the year 2004, improvement was greater among the Hispanic group, and by the year 2010, control rates were better among Hispanics than all other groups. In contrast, improvement in control rates among blacks was slower and became identical to the nonspecified group after the year 2002. At the end of the follow-up period, these 2 groups had control rates that were significantly lower than in the white and Hispanic groups. 
Multivariable Analysis
For patients with hypertension who had BP readings during calendar year 2000, a mean of 51.5% (95% CI, 51.3%-51.6%) of months were controlled. This increased to 74.1% (95% CI, 74.0%-74.2%, PϽ0.001) of months for patients who had BP readings in 2010. Independent predictors of the percentage of months controlled in the final year included city, age group, race, duration of treatment (all PϽ0.0001), and sex (Pϭ0.002). After accounting for covariates, patients Ͻ55, 55 to Ͻ70, 70 to Ͻ80, and Ն80 years old had adjusted final percent elevated (the percentage of months with elevated BP in the final year) of 32.6%, 29.7%, 29.5%, and 29.3%, respectively. Duration of treatment (months in the data set) was significantly associated with an improved rate of control in the final year, after accounting for other covariates. The adjusted final percent elevated for blacks, Hispanics, and whites was 33.9%, 30.3%, and 28.3%, respectively. The adjusted final percent elevated was 29.9% for females and 30.7% for males.
To evaluate within-subject change over time, the first repeated-measures analysis examined change from each subject's year of being identified as hypertensive compared with their last year in the data set. The time effect was significant (PϽ0.0001), which indicates that BP control rates improved within patients. On average, the proportion of months with elevated BP changed from 0.53Ϯ0.33 in the first year to 0.28Ϯ0.36 in the patient's last year (online-only Data Supplement Table I Table III) .
Discussion
The main finding of the present study was a steady improvement in BP control among all groups of veterans. Overall control rates among patients with hypertension improved from 43. implemented many changes to improve care in the last decade. Among the changes that influence hypertension control, a prominent role is attributable to electronic health records, the ability to provide feedback to patients and healthcare professionals regarding patient appointments, prescription refills, regimen adjustment, and the need to meet existing national performance measures. Automatic reminders in the electronic health record warned all providers when BP was elevated. Another important variable was the ability to provide frequent appointments to patients until BP was under control. This improved patient involvement, led to adherence to medication, and ensured patient compliance. Furthermore, patient involvement was enhanced by providing (free of charge) BP monitors for home measurements, which enabled patients to store and transmit values electronically, and by establishing virtual communication with providers.
Because the group of patients followed up in VA medical centers receive care for free or for very little cost, there were no major issues with access to health care or cost of therapy. Usual and important issues in healthcare delivery, such as poor adherence to medications, clinician inertia, clinician and patient education, and unhealthy lifestyles, were aggressively addressed.
National trends to use nonphysician healthcare professionals such as nurses, physician assistants, nutritionists, and pharmacists as part of the management team were also pursued in many VA medical centers. Control rates achieved in this cohort were better than national data published by Egan et al 12 and the National Health and Nutrition Examination Survey 2007 to 2008. 12, 13 In the most recent National Health and Nutrition Survey, 13 data indicate improvement in control rate from 35% to 50%. The 50% control rate is particularly important and meets the Healthy People 2010 objective. In the present study, control rates reached Ͼ76% during the summer of 2010. The difference in control rates can be explained in part by the number of patients treated rather than the ability to reduce BP to normal levels in individual patients. In the National Health and Nutrition Examination Survey, even under the best circumstances, only 73% of patients received antihypertensive medication. Data from the Washington, DC, VA medical center indicate that Ͼ90% of patients with hypertension are under treatment (data not shown). Thus, identification and treatment of patients with hypertension in the community may be the most efficient way to improve control rates. In the present study, BP improvement continued throughout the study period (2000 -2010) . Control rates improved in all age groups, including the old and very old (octogenarians), and in all ethnic groups. Blacks lagged slightly behind. In the study by Egan et al, 12 the highest percentage of patients treated and not controlled was in the age group Ն60 years. BP control in the older groups, especially among octogenarians, is of particular interest. This subgroup is thought of as difficult to control and more prone to adverse events; however, this subgroup achieved control rates similar to the younger subgroups in the present study. Recent data from the Hypertension in the Very Elderly Trial (HYVET) 14 suggest that BP control in this population can result in substantial benefits from prevention of cardiovascular complications. An analysis of mortality data from the present study cohort also suggests continuous improvement in all-cause mortality in all age groups, including the octogenarians (data not shown). 15 The elimination of difference in control rates in the Hispanic versus white racial groups is similarly encouraging. BP control improved among blacks but did not achieve the same rate of control as in whites. The reason for this difference is not clear.
Antihypertensive drug use for the 15 hospitals in the present study was not available in the database at the time of this writing; however, data previously published from the national VA pharmacy repository, 16 which includes the 15 VA hospitals in the present study, indicate the following changes in drug use from 2000 to 2006: Use of angiotensinconverting enzyme inhibitors increased from 56% in 2000 to 64% in 2006; use of ␤-blockers increased from 38% to 50%; use of thiazide diuretics increased from 33% to 42%; and use of calcium channel blockers decreased from 43% to 38%. Use of ␣-blockers and loop diuretics remained unchanged. Use of angiotensin receptor blockers increased from 3% to 12%. The percentage of patients using 3 drugs increased from 23% to 26%, and the percentage of patients using Ն4 drugs increased from 13% to 16%.
Study Limitations
Specific information on adherence and compliance to medication was not available for the 15 hospitals included in the present study. During visits, compliance was monitored by verbally asking patients, "Do you take your pills?" Pill count was not performed, and no other objective method of compliance monitoring was used.
Conclusions
Findings from the present study indicate a steady improvement in BP control from 2000 to 2010 irrespective of age, sex, ethnicity, or climate.
